Which statement about Arista AH NOT indicated for is accurate?

• A. Orthopedic and cardiovascular procedures
• B. Neurological and ophthalmic procedures, postpartum bleeding, or menorrhagia
• C. Dermatologic procedures
• D. Obstetric surgeries

Answer: (B)

Arista AH is a topical hemostatic agent used to help control surface bleeding by providing a physical matrix for clot formation in many surgical fields. It is indicated for orthopedic and cardiovascular procedures, dermatologic procedures, and obstetric surgeries, where bleeding is on accessible surfaces and the agent can be applied directly to the site.

The statement that Arista AH is not indicated for neurological and ophthalmic procedures, postpartum bleeding, or menorrhagia identifies areas where this product should not be used. In the brain and eye, introducing a foreign hemostatic material carries specific risks and those spaces require specialized hemostatic approaches. For postpartum bleeding or menorrhagia, the clinical context is within the uterine environment, where different therapies and indications apply, and Arista AH isn’t indicated for intrauterine use to manage obstetric bleeding.

So the option describing these not-indicated contexts correctly reflects the product’s appropriate uses and its limitations.